The Athlete's Foot Treatment Manufacturing OTC industry provides highly inelastic products that have no direct substitutes in the market and therefore benefits from a steady stream of revenue, despite the high internal and external competition it experiences. Over the next five years, the industry is expected to continue growing. Increasing health awareness is expected to send a greater number of people to gyms, swimming pools, showers, and locker rooms, all of which are transmitters of athlete's foot infections. As awareness about athlete's foot increases, people are anticipated to pay greater attention to preventative-care products and the treatment of the infection during the early stages. Some forms of preventative care do not benefit the industry and may, therefore, cut into future sales by decreasing the number of people requiring treatment.
This industry manufactures medications to treat common fungal infections of the skin that cause scaling, flaking and itching. This industry includes products that are sold without a prescription.
The report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecast, growth rates and an analysis of the industry key players and their market shares.